Gufic Biosciences is currently trading at Rs. 88.90, up by 1.30 points or 1.48% from its previous closing of Rs. 87.60 on the BSE.
The scrip opened at Rs. 87.55 and has touched a high and low of Rs. 90.50 and Rs. 86.80 respectively. So far 20916 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 99.60 on 24-Oct-2017 and a 52 week low of Rs. 40.90 on 17-Nov-2016.
Last one week high and low of the scrip stood at Rs. 93.50 and Rs. 85.55 respectively. The current market cap of the company is Rs. 691.51 crore.
The promoters holding in the company stood at 69.98%, while institutions and non-institutions held 8.88% and 21.14% respectively.
Gufic Biosciences has received an approval for the Scheme of Amalgamation of Gufic Lifesciences with itself. The Board of Directors of the Company at its meeting held on November 09, 2017 has approved the same.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |